Effects of photodynamic therapy on glioma spheroids

British Journal of Neurosurgery

Volumn 11, Issue 3, 1997, Pages 196-205

  Terzis, A J A ^a   Dietze, A ^a   Bjerkvig, R ^b   Arnold, H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Glioma; Haematoporphyrin derivative; Invasiveness; Photodynamic therapy; Three dimensional culture

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE;

ARGON LASER; ARTICLE; BRAIN CELL; CANCER CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY; GLIOMA; GLIOMA CELL; GROWTH RATE; HUMAN; HUMAN CELL; MORPHOLOGY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR CELL; TUMOR SPHEROID;

ADULT; ANIMALS; BRAIN; CELL DIVISION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PHOTOCHEMOTHERAPY; RATS; RATS, WISTAR; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0030989846     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688699746249     Document Type: Article

References (42)

1. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983;52:997-1007.
2. EORTC Brain Tumour Group. Evaluation of CCNU, VM-26 plus CCNU, and Procarbazine in supratentorial brain gliomas. J Neurosurg 1981;55:27-31.
3. Walker MD. Brain tumour study group: a survey of current activities. Nat Cancer Inst Monogr 1977;46:209-12.
4. Cheng MS, McKean J, Boisvert D. Photoradiation therapy: current status and applications in the treatment of brain tumours. Surg Neurol 1986;25:423-35.
5. Kaye AH, Morstyn G, Apuzzo MLJ. Photoradiation therapy and its potential in the management of neurological tumours. J Neurosurg 1988;69:1-14.
6. Kostron H, Fritsch E, Grunert V. Photodynamic therapy of malignant brian tumours: a phase I/II trial. Br J Neurosurg 1988;2:241-8.
7. Laws ER, Wharen RE Jr, Andersen RE. Photodynamic therapy of brain tumours. In: Iori G, Perria C (eds) Photodynamic Therapy of Tumours and Other Diseases. Progetto Padova: Edizioni Libreria 1985:311-16.
8. McCulloch GAJ, Forbes IJ, Lee See K, Cowled PA, Jacka FJ, Ward AB. Photothearpy in malignant brain tumours. In Doiron DR, Gomer CJ (eds) Porphyrin Localization and Treatment of Tumours. New York: Alan R Liss 1984:709-17.
9. Muller PJ, Wilson BC. Photodynamic therapy of malignant primary brain tumours: clinical effects, postoperative ICP and light penetration in the brain. Photochem Photobiol 1987;46:929.
10. Muller PJ, Wilson BC. Photodynamic therapy of malignant brain tumours. Can J Neurol Sci 1990;17:193-8.
11. Perria C, Capuzzo T, Cavagnaro G, Datti R, Francaviglia N, Rivano C, tercero VE. First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 1980;24:119-29.
12. Rounds DE, Jacques S, Shelden Ch, Shaller CA, Olson RS. Development of a protocol for photoradiation therapy of malignant brain tumours. Part I. Photosensitisation of normal brain tissue with hematoporphyrin derivative. Neurosurgery 1982;11:500-5.
13. Foote CS. Chemical mechanisms of photodynamic action. Proc. SPIE Institute: Advanced Optical Technologies on Photodynamic Therapy IS 1990;6:115-26.
14. Gomer CJ, Ferrario A. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumour model. Cancer Res 1990;50:3985-90.
15. Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol 1992;55:931-48.
16. Chan WS, Marshall JF, Lam GYF, Hart IR. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminium sulfonated phthalocyanine in mice bearing transplantable tumours. Cancer Res 1988;48:3040-4.
17. Kaye AH, Hill JS. Photoradiation therapy of brain tumours: Laboratory and clinical studies. In: Morstyn G, Kaye AH (eds) Phototherapy of Cancer. London: Harwood 1990:101-18.
18. Daye AH, Morstyn G. Photoradiation therapy causing selective tumour kill in a rat glioma model. Neurosurgery 1987;20:408-15.
19. Kessel D. Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy. Photochem Photobiol 1984;39:851-9.
20. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumour. Cancer Res 1976;36:2326-9.
21. Henderson BW, Fingar VH. Oxygen limitation of direct tumour cell killing during photodynamic treatment. Photochem Photobiol 1989;49:299-304.
22. Les SK, Forbes IJ, Betts WH. Oxygen dependency of phototoxicity with haematoporphyrin derivative. Photochem Photobiol 1984;39:631-4.
23. Truscott TG, McLean AJ, Phillips MR, Foulds WS. Detection of haematoporphyrin derivative and haematoporphyrin excited states in cell environments. Cancer Lett 1988;41:31-5.
24. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundström C, Carsson E, et al. Formation and growth of multicellular spheroids of human origin. Int J Cancer 1983;31:523-33.
25. Mueller-Klieser W. Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 1987;113:101-22.
26. Sutherland RM. Cell and environment interactions in tumour microregions: the multicellular spheroid model. Science 1988;240:177-84.
27. Sutherland RM, Freyer J, Mueller-Klieser W. Cellular growth and metabolic adaptations to nutrient stress environments in tumour microregions. Int J Rad Oncol Biol Phys 1986;12:611-15.
28. Akslen LA, Andersen KJ, Bjerkvig R. Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 1988;8:797-804.
29. Yuhas JM, Li AP, Martinez AO, Ladman AJ. A simplified method for production and growth of mutlicellular spheroids. Cancer Res 1977;37:3639-43.
30. Bjerkvig R. Reaggregation of fetal rat brain cells in a stationary culture system II: ultrastructure characterisation. In Vitro Cell Dev Biol 1986;22:193-200.
31. Bjerkvig R, Steinvaag SK, Laerum OD. Reaggregation of fetal rat brain cells in a stationary culture system. I: methodology and cell identification. In Vitro Cell Dev Bio 1986;22:180-92.
32. Honegger P, Lenoir P, Farvrod P. Growth and differentiation of aggregating fetal brain cells in serum free defined medium. Nature 1979;282:305-7.
33. Trapp BD, Honegger P, Richelson E. Morphological differentiation of mechanically dissociated fetal rat brain in aggregating cell cultures. Brain Res 1982;160:235-52.
34. Trapp BD, Webster HD, Johnson D, Quarles RH, Cohen SR, Murray MR. Myelin formation in rotation-mediated aggregating cell cultures: Immunocytochemical, electron microscopic and biochemical observations. J Neurosci 1982;2:986-93.
35. Gundersen HJG, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microscopy 1987;147:229-63.
36. Kaye AH, Morstyn G, Brownbill D. Adjuvant high dose photoradiation therapy in the treatment of cerebral glioma. A phase I-II study. J Neurosurg 1987;67:500-5.
37. 4 cells in vitro. Arch Gesschwulstforsch 1981;51:45-50.
38. West CML, Moore JV. Mechanisms behind the resistance of spheroids to photodynamic treatment: a flow cytometry study. Photochem Photobiol 1992;55:425-30.
39. Epifanova OI. Mechanisms underlying the differential sensitivity of proliferating and resting cells to external factors. Int Rev Cytol 1977;5(Suppl.):303-35.
40. Barel A, Jori G, Perin A, Romandini P, Pagnan A, Buffanti S. Role of high-, low- and very low-density lipoprotein in the transport and tumour-delivery of hematoporphyrin in vitro. Cancer 1986;32:145-50 (Letter).
41. Durand RE. Cell cycle kinetics in an in vitro tumour model. Cell Tissue Kinet 1976;9:403-12.
42. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55:145-57.